Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Moderna Inc shares valued at $8,736 were sold by Hussain Abbas on Jun 11 ’25. At $28.00 per share, Hussain Abbas sold 312 shares. The insider’s holdings dropped to 580 shares worth approximately $15578.8 following the completion of this transaction.
Also, Hussain Abbas purchased 312 shares, netting a total of over 8,736 in proceeds.
Before that, Bancel Stephane had added 160,314 shares to its account. In a trade valued at $5,004,318, the Chief Executive Officer bought Moderna Inc shares for $31.22 each. Upon closing the transaction, the insider’s holdings increased to 160,314 shares, worth approximately $247.4 million.
As published in their initiating research note from Citigroup on March 13, 2025, Moderna Inc [MRNA] has been a Neutral and the price target has been revised to $40. Analysts at Barclays downgraded the stock from ‘”an Overweight”‘ to ‘”an Equal weight”‘ outlook in a report released in mid February. As of January 29, 2025, Goldman has decreased its “Buy” rating to a “Neutral” for MRNA. Earlier on December 18, 2024, Argus downgraded its rating. Their new recommendation was “a Hold” for MRNA stock which previously was a “a Buy”.
Analyzing MRNA Stock Performance
On last trading session,, Moderna Inc [NASDAQ: MRNA] rose 0.22% to $26.86. The stock’s lowest price that day was $26.135, but it reached a high of $26.96 in the same session. During the last five days, there has been a surge of approximately 5.13%. Over the course of the year, Moderna Inc shares have dropped approximately -79.87%. Shares of the company reached a 52-week high of $48.92 on 01/07/25 and a 52-week low of $23.15 on 04/07/25.
Support And Resistance Levels for Moderna Inc (MRNA)
According to the 24-hour chart, there is a support level at 26.34, which, if violated, would cause prices to drop to 25.83. In the upper region, resistance lies at 27.17. The next price resistance is at 27.48. RSI (Relative Strength Index) is 51.76 on the 14-day chart, showing neutral technical sentiment.
Is Moderna Inc subject to short interest?
Stocks of Moderna Inc saw a sharp rise in short interest on 2025-05-30 jumping by 5.64 million shares to 65.86 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 60.22 million shares. A jump of 8.56% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 4.73 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.73.
Which companies own the most shares of Moderna Inc (MRNA)?
In terms of Moderna Inc share price expectations, FactSet research, analysts set an average price target of 47.5 in the next 12 months, up nearly 77.24% from the previous closing price of $26.8. Analysts anticipate Moderna Inc stock to reach 50 by 2025, with the lowest price target being 45. In spite of this, 17 analysts ranked Moderna Inc stock as Buy at the end of 2025. On December 10, 2024, BofA Securities assigned a price target of “an Underperform” to the stock and resumed coverage with a $41.
